1. Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma;Dutcher;Oncology (Williston Park),2002
2. Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities;Jonasch;Oncologist,2001
3. KEYNOTE-006 Investigators. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015
4. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial;Weber;Lancet Oncol,2015
5. NSCLC - immunogenic after all?;Kallen;J Thorac Dis,2011